Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,002 public trials 1,214 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Recruiting

The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

NCT06118723

Conditions: Astrocytoma, Astrocytoma, Grade III, Astrocytoma, Grade IV, +24 more
Locations: University of California, San Francisco (UCSF) San Francisco, California, United States

Massachusetts General Hospital Boston, Massachusetts, United States

University Hospitals Leuven Leuven, Belgium

Universitätsklinikum Heidelberg Heidelberg, Baden-Wurttemberg, Germany

View Trial Details

Recruiting

MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy)

NCT06041555

Conditions: Astrocytoma, Cervix Cancer, Female Urogenital Diseases, +37 more
Locations: Hôpital Lyon Sud/ service de Radiothérapie Oncologie Lyon, France

View Trial Details

Recruiting

Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients

NCT06154668

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: CHU Grenoble Alpes Grenoble, France

View Trial Details

Recruiting

Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma

NCT05525273

Conditions: Craniopharyngioma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations: Department of Endocrinology Lund, Sweden

View Trial Details

Recruiting

Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON)

NCT06255210

Conditions: Cranial Nerve Diseases, Esthesioneuroblastoma, Olfactory, Neoplasms, +12 more
Locations: Eye & ENT Hospital of Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

NCT04282044

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +64 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

Stanford University Stanford, California, United States

View Trial Details

Recruiting

A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta

NCT04253015

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +14 more
Locations: St. Anna Kinderkrebsforschung Vienna, State of Vienna, Austria

Centre Oscar Lambret Lille, France

Hôpital de la Timone, Hôpital des Enfants Marseille, France

Institut Curie Paris, France

View all 13 locations

View Trial Details

Recruiting

Predictive Value of Soluble CD146 in Glioblastoma Patients

NCT06001281

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Service de Neuro-oncologie Marseille, France

View Trial Details

Recruiting

Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations

NCT06229340

Conditions: Colonic Diseases, Colorectal Cancer Recurrent, Colorectal Neoplasms, +33 more
Locations: Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint Petersburg, Russian Federation Saint Petersburg, Russia

View Trial Details

Recruiting

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

NCT05746897

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +37 more
Locations: NEXT Oncology, Dallas Dallas, Texas, United States

Next Oncology, Virginia Cancer Specialists Fairfax, Virginia, United States

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions